UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 112

Sortiert nach

A phase II study evaluating the safety and efficacy of an adenovirus-ΔLMP1-LMP2 transduced dendritic cell vaccine in patients with advanced metastatic nasopharyngeal carcinoma

Annals of oncology, 2012-04, Vol.23 (4), p.997-1005

2012

Link zum Volltext

Verfügbarkeit prüfen

Quality of life (QoL) analyses from OPTIMAL (CTONG-0802), a phase III, randomised, open-label study of first-line erlotinib versus chemotherapy in patients with advanced EGFR mutation-positive non-small-cell lung cancer (NSCLC)

Annals of oncology, 2013-06, Vol.24 (6), p.1615-1622

2013

Link zum Volltext

Verfügbarkeit prüfen

Cancer initiatives in developing countries

Annals of oncology, 2006-07, Vol.17 (suppl-8), p.viii24-viii31

Mellstedt, H.

2006

Link zum Volltext

Verfügbarkeit prüfen

Weekly AUC2 carboplatin in acquired platinum-resistant ovarian cancer with or without oral phenoxodiol, a sensitizer of platinum cytotoxicity: the phase III OVATURE multicenter randomized study

Annals of oncology, 2014-01, Vol.25 (1), p.160-165

2014

Link zum Volltext

Verfügbarkeit prüfen

Phase II randomized study of trabectedin given as two different every 3 weeks dose schedules (1.5 mg/m2 24 h or 1.3 mg/m2 3 h) to patients with relapsed, platinum-sensitive, advanced ovarian cancer

Annals of oncology, 2009-11, Vol.20 (11), p.1794-1802

2009

Link zum Volltext

Verfügbarkeit prüfen

The role of serum uric acid as an antioxidant protecting against cancer: prospective study in more than 28 000 older Austrian women

Annals of oncology, 2007-11, Vol.18 (11), p.1893-1897

2007

Link zum Volltext

Verfügbarkeit prüfen

Prospective analysis of quality of life in elderly patients treated with adjuvant chemotherapy for non-small-cell lung cancer

Annals of oncology, 2013-06, Vol.24 (6), p.1630-1639

2013

Link zum Volltext

Verfügbarkeit prüfen

Long-term outcome prediction by clinicopathological risk classification algorithms in node-negative breast cancer—comparison between Adjuvant!, St Gallen, and a novel risk algorithm used in the prospective randomized Node-Negative-Breast Cancer-3 (NNBC-3) trial

Annals of oncology, 2009-02, Vol.20 (2), p.258-264

2009

Link zum Volltext

Verfügbarkeit prüfen

A phase I–II study of weekly oxaliplatin, 5-fluorouracil continuous infusion and preoperative radiotherapy in locally advanced rectal cancer

Annals of oncology, 2005-07, Vol.16 (7), p.1140-1146

2005

Link zum Volltext

Verfügbarkeit prüfen

Phase I trial of ixabepilone plus pegylated liposomal doxorubicin in patients with adenocarcinoma of breast or ovary

Annals of oncology, 2010-10, Vol.21 (10), p.2075-2080

2010

Link zum Volltext

Verfügbarkeit prüfen

Questioning specialists' attitudes to breast cancer follow-up in primary care

Annals of oncology, 2007-09, Vol.18 (9), p.1467-1476

2007

Link zum Volltext

Verfügbarkeit prüfen

Neo-adjuvant and adjuvant chemotherapy of gastric cancer

Annals of oncology, 2007-06, Vol.18 (suppl-6), p.vi120-vi123

2007

Link zum Volltext

Verfügbarkeit prüfen

High prevalence of BRCA1 deletions in BRCAPRO-positive patients with high carrier probability

Annals of oncology, 2007-06, Vol.18 (suppl-6), p.vi86-vi92

2007

Link zum Volltext

Verfügbarkeit prüfen

Phase II study of S-1, an oral fluoropyrimidine, in patients with advanced or recurrent cervical cancer

Annals of oncology, 2011-06, Vol.22 (6), p.1353-1357

2011

Link zum Volltext

Verfügbarkeit prüfen

Predictors of state-of-the-art management of early breast cancer in Switzerland

Annals of oncology, 2011-03, Vol.22 (3), p.618-624

2011

Link zum Volltext

Verfügbarkeit prüfen

Participation of elderly patients in registration trials for oncology drug applications in Japan

Annals of oncology, 2010-10, Vol.21 (10), p.2112-2118

2010

Link zum Volltext

Verfügbarkeit prüfen

Good clinical response of breast cancers to neoadjuvant chemoendocrine therapy is associated with improved overall survival

Annals of oncology, 2005-02, Vol.16 (2), p.267-272

2005

Link zum Volltext

Verfügbarkeit prüfen

Advanced epithelial ovarian cancer : 1998 consensus statements

Annals of oncology, 1999, Vol.10, p.87-92

1999

Link zum Volltext

Verfügbarkeit prüfen

Phase II trial of pemetrexed disodium (ALIMTA®, LY231514) in chemotherapy-naïve patients with advanced non-small-cell lung cancer

Annals of oncology, 2002-05, Vol.13 (5), p.737-741

2002

Link zum Volltext

Verfügbarkeit prüfen

The contribution of molecular markers to the prediction of response in the treatment of breast cancer: A review of the literature on HER-2, p53 and BCL-2

Annals of oncology, 2000-06, Vol.11 (6), p.647-663

2000

Link zum Volltext

Verfügbarkeit prüfen

Role of tumour markers, cytogenetics

Annals of oncology, 1999, Vol.10 (suppl-4), p.S145-S149

LAMERZ, R

1999

Link zum Volltext

Verfügbarkeit prüfen

Panitumumab a novel drug in cancer treatment

Annals of oncology, 2007-06, Vol.18 (suppl-6), p.vi16-vi21

2007

Link zum Volltext

Verfügbarkeit prüfen

Dietary intake of fruit and vegetable and lung cancer risk: a case–control study in Harbin, northeast China

Annals of oncology, 2007-02, Vol.18 (2), p.388-392

2007

Link zum Volltext

Verfügbarkeit prüfen

Conformal irradiation for hepatobiliary malignancies

Annals of oncology, 1999, Vol.10 (suppl-4), p.S221-S225

1999

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 112

Suche als RSS-Feed

Aktive Filter

ThemaHealth Aspects

ThemaOncology

Zeitschrift / SerieAnnals Of Oncology

ThemaMedical Sciences

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(112)
Mit Volltextzugriff
(112)

Publikationsform

Artikel
(112)

Sprache

Englisch
(112)

Erscheinungsjahr

n.n

Thema

Biological And Medical Sciences
(112)
Humans
(95)
Pharmacology. Drug Treatments
(87)
Antineoplastic Agents
(85)
Female
(63)
Chemotherapy
(49)
Middle Aged
(43)
Tumors
(42)
Aged
(38)
Adult
(37)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(35)
Male
(29)
Treatment Outcome
(25)
Gynecology. Andrology. Obstetrics
(18)
Breast Cancer
(17)
Lung Neoplasms - Drug Therapy
(17)
Ovarian Neoplasms - Drug Therapy
(16)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(15)
Ovarian Cancer
(15)

14 weitere anzeigen...

Weniger anzeigen...

Kollektion

EZB Free E-Journals
(112)
WK Lippincott Williams & Wilkins–Connect here FIRST to enable access
(112)
MEDLINE
(95)
IngentaConnect Journals
(13)
Ingenta.com
(11)

Menü

Weitere Dienste

Einstellungen

A phase II study evaluating the safety and efficacy of an adenovirus-ΔLMP1-LMP2 transduced dendritic cell vaccine in patients with advanced metastatic nasopharyngeal carcinoma

Quality of life (QoL) analyses from OPTIMAL (CTONG-0802), a phase III, randomised, open-label study of first-line erlotinib versus chemotherapy in patients with advanced EGFR mutation-positive non-small-cell lung cancer (NSCLC)

Cancer initiatives in developing countries

Weekly AUC2 carboplatin in acquired platinum-resistant ovarian cancer with or without oral phenoxodiol, a sensitizer of platinum cytotoxicity: the phase III OVATURE multicenter randomized study

Phase II randomized study of trabectedin given as two different every 3 weeks dose schedules (1.5 mg/m2 24 h or 1.3 mg/m2 3 h) to patients with relapsed, platinum-sensitive, advanced ovarian cancer

The role of serum uric acid as an antioxidant protecting against cancer: prospective study in more than 28 000 older Austrian women

Prospective analysis of quality of life in elderly patients treated with adjuvant chemotherapy for non-small-cell lung cancer

Long-term outcome prediction by clinicopathological risk classification algorithms in node-negative breast cancer—comparison between Adjuvant!, St Gallen, and a novel risk algorithm used in the prospective randomized Node-Negative-Breast Cancer-3 (NNBC-3) trial

A phase I–II study of weekly oxaliplatin, 5-fluorouracil continuous infusion and preoperative radiotherapy in locally advanced rectal cancer

Phase I trial of ixabepilone plus pegylated liposomal doxorubicin in patients with adenocarcinoma of breast or ovary

Questioning specialists' attitudes to breast cancer follow-up in primary care

Neo-adjuvant and adjuvant chemotherapy of gastric cancer

High prevalence of BRCA1 deletions in BRCAPRO-positive patients with high carrier probability

Phase II study of S-1, an oral fluoropyrimidine, in patients with advanced or recurrent cervical cancer

Predictors of state-of-the-art management of early breast cancer in Switzerland

Participation of elderly patients in registration trials for oncology drug applications in Japan

Good clinical response of breast cancers to neoadjuvant chemoendocrine therapy is associated with improved overall survival

Advanced epithelial ovarian cancer : 1998 consensus statements

Phase II trial of pemetrexed disodium (ALIMTA®, LY231514) in chemotherapy-naïve patients with advanced non-small-cell lung cancer

Postoperative dose-dense sequential chemotherapy with epirubicin, paclitaxel and CMF in patients with high-risk breast cancer: safety analysis of the Hellenic Cooperative Oncology Group randomized phase III trial HE 10/00

The contribution of molecular markers to the prediction of response in the treatment of breast cancer: A review of the literature on HER-2, p53 and BCL-2

Role of tumour markers, cytogenetics

Panitumumab a novel drug in cancer treatment

Dietary intake of fruit and vegetable and lung cancer risk: a case–control study in Harbin, northeast China

Conformal irradiation for hepatobiliary malignancies

Aktive Filter

Suchergebnisse filtern